[{"Assets_0_Q3_USD":1751481000.0,"EarningsPerShareDiluted_3_Q3_USD":3.85,"EarningsPerShareDiluted_1_Q3_USD":1.24,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":86206000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":86198000.0,"EarningsPerShareBasic_3_Q3_USD":3.91,"EarningsPerShareBasic_1_Q3_USD":1.26,"StockholdersEquityConverted_0_Q3_USD":202722000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":87633000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":87667000.0,"StockholdersEquity_0_Q3_USD":202418000.0,"NetIncomeLossConverted_3_Q3_USD":337224000.0,"NetIncomeLossConverted_1_Q3_USD":108837000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":303745000.0,"CommonStockSharesOutstanding_0_Q3_shares":85888000.0,"CommonStockSharesConverted_0_Q3_shares":105594000.0,"RevenuesConverted_1_Q3_USD":605303000.0,"RevenuesConverted_3_Q3_USD":1801462000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20191031"}]